spacer
home > epc > Autumn 2008
PUBLICATIONS

European Pharmaceutical Contractor

epc
Autumn 2008
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. EPC provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in the current issue of EPC.
   
Text
PDF
bullet
Marketplace & Business
Advanced eClinical technology can help the pharmaceutical industry to improve productivity and reduce costs in order to meet the demands of a difficult marketplace environment, explains Wade Wirta at Perceptive Informatics  
view
download pdf
There’s no competitive advantage in submissions management, so why be dragged down by the process? Adam Sherlock of ISI says it is time to let someone else do it  
view
download pdf
Margaret Osborn of Synergy Marketing Group, Inc, applies the power of electronic marketing and demonstrates the ways in which it drives awareness, demand and leads  
view
download pdf
Jane Nathan at PharmaEd emphasises the importance of appropriate medical training for clinical teams  
view
download pdf
bullet
Legal & Regulatory
Colin Bell at Brabners Chaffe Street discusses the need for effective IP strategies for pharmaceutical innovations  
view
download pdf
Claire Madden-Smith at Molecular Profiles examines the most effective lifecycle management strategies and the role of intellectual property  
view
download pdf
Philip Payne at RSSL Pharma believes that for any company working in the pharmaceutical industry complying with the regulations and guidelines issued by any of the regulatory bodies represents both a commitment and a challenge  
view
download pdf
bullet
Clinical Development
Joop van Gerven and Justin Hay of CHDR discuss how carefully chosen biomarkers can easily be incorporated into early phase drug studies, providing guidance for important decisions concerning a drug’s future  
view
download pdf
Lisa L Mathis at the Paediatric and Maternal Health Staff Office of New Drugs, FDA, argues the case for better paediatric drug testing  
view
download pdf
Graham Wylie of the MRN discusses the use of clinical trial support organisations (CTSOs) for home-based drug administration in clinical trials with parenteral therapies  
view
download pdf
Janet Edwards of AstraZeneca explores how partnership and innovation works for global clinical development  
view
download pdf
bullet
DRUG DISCOVERY, DELIVERY & THERAPEUTICS
Peter Gaskin at Aptuit Consulting assesses the failure of neuroprotectives in the clinic and questions whether the lessons can be applied to the design of animal models for other CNS indications  
view
download pdf
Natalie Appels and Ilona Verbaan-Giebelen of NOTOX BV propose in vitro testing alternatives for designing a better preclinical and clinical package, reducing animal use and drug development costs  
view
download pdf
In liquid handling quality assurance, location is vital for improving quality in drug discovery and development processes, claims George Rodrigues at ARTEL  
view
download pdf
bullet
Data Management & IT Solutions
Is electronic data capture standardisation the next evolution in clinical trial productivity? Simon Hawken of eResearchTechnology, Inc explores this faster and cheaper method for data collection  
view
download pdf
bullet
LABS & Logistics
Intelligent automation and control solutions can optimise manufacturing performance and safeguard product quality, claims Walfried Laibacher of Honeywell Building Solutions  
view
download pdf
Don Riach at Marken outlines the challenges of temperature controlled pharmaceutical logistics and the role of the specialist courier company  
view
download pdf
Hermann Schulz of INTERLAB GmbH provides an update on the logistics of shipping biological samples across borders  
view
download pdf
bullet
ECG CORE LABS & CARDIAC SAFETY
James Conklin of ICON Medical Imaging charts the evolution of commercial imaging core laboratory technology systems  
view
download pdf
   
spacer



Published quarterly in
February, May,
August and November

News and Press Releases

Charles River Laboratories Makes Investments in High-Throughput Screening Infrastructure

WILMINGTON, Mass.--(BUSINESS WIRE)--Feb. 1, 2018-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced a new agreement which grants Charles River commercial access to AstraZeneca’s (NYSE: AZN) high-throughput screening (HTS) and compound management infrastructure. Through the agreement, Charles River will perform HTS programs for its clients utilizing AstraZeneca’s state-of-the-art HTS facility.
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence and Post Translational Modifications of a Monoclonal Antibody

RSSL

Monoclonal antibodies are an important class of biopharmaceuticals. They are expressed from living cells and therefore, are subject to complex biochemical pathways. Not all of these pathways are fully understood and many are known to be sensitive to subtle environmental changes during production. These changes may affect the final biopharmaceutical sequence, structure and post-translational modifications. This is in addition to any changes that may occur during subsequent purification. This means that the final product from one batch may be subtly different from another batch. Furthermore, each batch is a heterogeneous mix of similar molecules. Analysis of the degree of batch-tobatch variation, and batch heterogeneity, is therefore, very important to establish in order to be confident that the drug is safe and effective for medicinal use.
More info >>

Industry Events

Clinical Trial Supply Europe 2018

14-15 March 2018, Milan, Italy

CTS Europe will be returning for the 19th edition next March. This prestigious event will welcome   representatives from 6 of the top 10 pharmaceutical companies in Europe, who will be joined by leading biotech companies across the continent to jointly find solutions for your clinical trial supply problems and discuss changes in the industry.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement